TherAppX is a Canadian startup founded in 2018 with a mission to simplify access to trusted health apps for patients through its ecosystem. The company's flagship product, TherAppX Review, offers an efficient assessment data generation process for health apps. Additionally, AppGuide provides trusted content, assessments, and guidance for patients and health professionals. With a recent $2.30M Pre Seed Round investment on 11 November 2022, the startup attracted funding from notable investors including Desjardins Capital, Investissement Québec, Health Technology Catalyst | CTS, and Propulia Capital. TherAppX aims to become the global reference for data-driven decisions in the distribution and reimbursement of health apps within the Health Care and Information Technology industries. The startup's focus on simplifying access to health apps aligns with the growing demand for digital healthcare solutions. More information about TherAppX can be found at therappx.com.
No recent news or press coverage available for TherAppX.